Last quarter (Q3 2022), Mochida Pharmaceutical Co., Ltd.'s total revenue was $28.19B, a decrease of -8.48% from the same quarter last year. In Q3, Mochida Pharmaceutical Co., Ltd.'s net income was $4.16B. See Mochida Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Total Revenue	$ 81.25B	$ 110.18B	$ 103.00B	$ 101.80B	$ 109.65B	$ 106.75B
Cost of Revenue	$ 37.52B	$ 50.63B	$ 48.20B	$ 49.88B	$ 55.48B	$ 53.18B
Gross Profit	$ 43.73B	$ 59.55B	$ 54.79B	$ 51.92B	$ 54.17B	$ 53.57B
Operating Expense	$ 33.04B	$ 45.16B	$ 42.79B	$ 43.11B	$ 43.58B	$ 41.90B
Operating Income	$ 10.69B	$ 14.39B	$ 12.00B	$ 8.81B	$ 10.59B	$ 11.66B
Net Non Operating Interest Income Expense	$ 1.00M	$ 2.00M	$ 3.00M	$ 3.00M	$ 2.00M	$ 0.00
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ 10.44B	$ 14.59B	$ 11.90B	$ 6.27B	$ 11.64B	$ 12.12B
Tax Provision	$ 2.74B	$ 4.02B	$ 3.31B	$ 1.68B	$ 3.21B	$ 3.09B
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 7.70B	$ 10.57B	$ 8.59B	$ 4.60B	$ 8.44B	$ 9.02B
Basic EPS	$ 206.93	$ 277.39	$ 222.29	$ 117.56	$ 212.87	$ 227.28
Diluted EPS	$ 206.18	$ 277.39	$ 222.29	$ 117.56	$ 212.87	$ 227.28
Basic Average Shares	$ 112.28M	$ 38.10M	$ 38.63M	$ 39.12M	$ 19.81M	$ 39.70M
Diluted Average Shares	$ 112.28M	$ 38.10M	$ 38.63M	$ 39.12M	$ 39.23M	$ 39.70M
Dividend Per Share	$ 50.00	$ 90.00	$ 80.00	$ 80.00	$ 130.00	$ 85.00
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 70.56B	$ 95.79B	$ 90.99B	$ 92.99B	$ 99.06B	$ 95.09B
Net Income From Continuing And Discontinued Operation	$ 7.70B	$ 10.57B	$ 8.59B	$ 4.60B	$ 8.44B	$ 9.02B
Normalized Income	$ 8.01B	$ 10.72B	$ 8.85B	$ 6.71B	$ 7.92B	$ 8.94B
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ 1.00M	$ 3.00M
EBIT	$ 10.69B	$ 14.39B	$ 12.00B	$ 8.81B	$ 11.64B	$ 12.12B
EBITDA	$ 10.69B	$ 17.08B	$ 14.74B	$ 11.54B	$ 14.56B	$ 14.74B

Currency in USD

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing